FMC CORP Q1 FY26 Results

Summary

FMC Corporation reported first quarter 2026 revenue of $759 million, a 4 percent decrease compared to the prior year, though revenue excluding India was above the midpoint of guidance. The company experienced a consolidated GAAP net loss of $281 million and a 40 percent decline in Adjusted EBITDA to $72 million. Despite these declines, Q1 volume improved by 2 percent, driven by strong growth in EMEA and North America, with new active ingredient sales doubling year-over-year. Management reaffirmed its full-year 2026 outlook, expecting revenue of $3.60 billion to $3.80 billion and Adjusted EBITDA of $670 million to $730 million, while continuing to advance operational priorities and explore strategic options.

Key Highlights

1. 1

   FMC Corporation reported first quarter 2026 revenue of $759 million, marking a 4 percent decrease compared to Q1 2025.

2. 2

   The company recorded a consolidated GAAP net loss of $281 million for Q1 2026, a significant decline of $266 million versus the prior year.

3. 3

   Adjusted EBITDA for the first quarter stood at $72 million, representing a 40 percent decrease compared to Q1 2025.

4. 4

   Consolidated GAAP loss per diluted share was $2.25, down $2.13 versus Q1 2025, while adjusted loss per diluted share was $0.23, down 41 cents.

5. 5

   First quarter volume improved by 2 percent, driven by strong growth in EMEA and North America, with new active ingredient sales doubling year-over-year.

6. 6

   FMC reaffirmed its full-year 2026 revenue guidance of $3.60 billion to $3.80 billion and Adjusted EBITDA guidance of $670 million to $730 million.

7. 7

   Sales of new active ingredients are expected to be between $300 million and $400 million for the full year, representing growth of over 75 percent at the midpoint versus prior year.